However, this meta-analysis did not include central nervous system (CNS) tumors, even though the AGR2 overexpression had been detected in CNS tumors, including glioblastoma multiforme (GBM) and meningiomas [23,24,25]. Here, AGR2 is linked to glioblastoma.